Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) sunk -5.74% after the company announced that ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) has granted STA exclusive rights to commercialize Iclusig® (ponatinib) in Australia in patients with Philadelphia-positive (Ph+) leukemias. Under the terms of the agreement, STA will be responsible for obtaining marketing authorization and pricing and reimbursement approval of Iclusig and assisting ARIAD in regulatory filings for Iclusig in Australia. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $7.26 in last session, and closed at $6.88, while the day range of ARIA stock is $6.70 – $7.30. The stock showed a negative weekly performance of -13.02%.
Galena Biopharma Inc (NASDAQ:GALE)’s plan to give away a month’s free supply of a potentially lethal painkiller caused GALE stock to plummet Monday. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $4.54, in last session and closed at $4.22, by losing -19.92%. The 52 week range of GALE is $1.65 – $7.77. Company’s market capitalization is $444.10million.
Zogenix Inc. (NASDAQ:ZGNX) reports preliminary Q4 gross sales of its Sumavel DosePro migraine-relief drug totaled $14M, with unit shipments rising 2.2% Q/Q to 141,780. Zogenix, Inc. (NASDAQ:ZGNX) stock decreased -7.22% and finished the last session at $4.11. The EPS of the stock remained -0.44. Company’s market capitalization is $568.96million.
Peregrine Pharmaceuticals (NASDAQ:PPHM)’s shares declined 1.68% to $1.76. On January 18, 2014, Mr. Jeffrey L. Masten gave notice of resignation, effective February 20, 2014, as Vice President, Quality of Peregrine Pharmaceuticals, Inc. Peregrine Pharmaceuticals (NASDAQ:PPHM) stock opened the session at $1.83, and closed the session at $1.68. The 52 week range of the PPHM stock remained $1.11 – $2.43 and the day range was $1.65 – $1.84.
Leave a Reply